How Dr. Scott Rocklage is a Leader in the Pharmaceutical Industry

Scott Rocklage, Ph.D., has worked in the biotechnology industry for over 30 years. He is a graduate the University of California, Berkeley, where he earned his B.S. in Chemistry. He then traveled across the country and became a student at the Massachusetts Institute of Technology, earning his Ph.D. in Chemistry. While at MIT, Dr. Scott Rocklage worked in the chemistry lab along with Richard Schrock who would go on to earn a Nobel Prize in Chemistry.

Starting out in the field of pharmaceuticals, Dr. Scott Rocklage worked in research and development of a few different biotechnology firms including Salutar and Catalytica. Eventually, he transitioned to executive level positions at these biotechnology firms as he showed great leadership and business skills.

At Nycomed Salutar, Dr. Rocklage was the Chief Executive Officer and President of the company. He also worked as the CEO and Chairman of the Board of Cubist Pharmaceuticals. His leadership and experience in the industry has led to three FDA approved drug applications; Teslascan, Cubicin, and Omniscan. He has been an inventor throughout his career and holds 30 U.S. patents. He is also a prolific author and has published more than 100 peer-reviewed articles in medical publications.

In 2003, Dr. Rocklage became a Venture Partner at 5AM Ventures and the Managing Partner in 2004. This firm provides venture capital to startup biotechnology companies. Like the other Partners at 5AM Ventures, Dr. Scott Rocklage’s deep experience in the industry allows him to spot great business opportunities which they then invest in. They also become highly involved in the companies they are invested in, sharing their knowledge and business skills in order to help these startups develop their innovative medical solutions and learn more about Scott Rocklage.

Dr. Scott Rocklage sits on the board of a number of biotechnology firms. He is the Chairman of the Board for Kinestral, Cidara, and Rennovia. He is also a Board Member for Pulmatrix and Epirus. These companies value is knowledge of R&D issues as well as how to effectively operate a successful company. He says one of his main tenants is to not stray too far away from your strengths, something that he has shown he has effectively done and more information click here.

More visit: https://ideamensch.com/scott-rocklage/

Comments are closed.